Bevacizumab, Ranibizumab Comparable for Macular DegenerationBevacizumab, Ranibizumab Comparable for Macular Degeneration

Investigators report no difference between the 2 agents for visual acuity at 1 year, but concern lingers over adverse events. Medscape Medical News

Source: Medscape Today Headlines - May 9, 2013 Category: Consumer Health News Tags: Ophthalmology News Source Type: news